Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Sodium bicarbonate 4.2% solution for injection 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sodium perchlorate 200mg/2ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin degludec 100units/ml solution for injection 3ml cartridges |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin degludec 100units/ml solution for injection 3ml pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Bevacizumab 1.25mg/0.05ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin degludec 200units/ml solution for injection 3ml pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lixisenatide 20micrograms/0.2ml solution for injection 3ml pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Lixisenatide 10micrograms/0.2ml solution for injection 3ml pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cisatracurium besilate 20mg/10ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cisatracurium besilate 10mg/5ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cisatracurium besilate 5mg/2.5ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Chloroprocaine 50mg/5ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cefuroxime 1mg/0.1ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Midazolam 5mg/2ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Dexamethasone 6.6mg/2ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Cefuroxime 300micrograms/0.3ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ephedrine 30mg/10ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Filgrastim 48million units/0.8ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sugammadex 200mg/2ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sugammadex 500mg/5ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methoxy polyethylene glycol-epoetin beta 30micrograms/0.3ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methoxy polyethylene glycol-epoetin beta 120micrograms/0.3ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methoxy polyethylene glycol-epoetin beta 360micrograms/0.6ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 25mg/3ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Icatibant 30mg/3ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ustekinumab 45mg/0.5ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Normal immunoglobulin human 480mg/3ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Normal immunoglobulin human 3.2g/20ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Apomorphine 2mg/2ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Magnesium sulphate 20% solution for injection 20ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Droperidol 2.5mg/1ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 7.5mg/0.15ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 10mg/0.2ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 15mg/0.3ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 25mg/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 20mg/0.4ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Oxycodone 50mg/1ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin human 500units/ml solution for injection 20ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ethanol solution for injection 2ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ribavirin 1.2g/12ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hydromorphone 50mg/1ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Liraglutide 18mg/3ml solution for injection pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Etanercept 50mg/1ml solution for injection 1ml pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Papaveretum 30mg/1ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Plerixafor 24mg/1.2ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Promethazine 50mg/2ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline 500micrograms/0.3ml (1 in 600) solution for injection pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Prilocaine 100mg/5ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Sildenafil 40mg/50ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Epoetin zeta 20,000units/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Epoetin zeta 30,000units/0.75ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Epoetin theta 1,000units/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Epoetin theta 3,000units/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Epoetin theta 4,000units/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Epoetin theta 5,000units/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Epoetin theta 10,000units/1ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Epoetin theta 2,000units/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Epoetin theta 30,000units/1ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Epoetin theta 20,000units/1ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Histamine dihydrochloride 500micrograms/0.5ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Denosumab 60mg/1ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Certolizumab pegol 200mg/1ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gadoteridol 0.5mmol/ml solution for injection 10ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gadoteridol 0.5mmol/ml solution for injection 15ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gadoteridol 0.5mmol/ml solution for injection 20ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Corifollitropin alfa 100micrograms/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Filgrastim 12million units/0.2ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Corifollitropin alfa 150micrograms/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ustekinumab 45mg/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Interferon alfa-2b 10million units/1ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Hepatitis B immunoglobulin human 500unit solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Paraldehyde 5g/5ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Normal immunoglobulin human 3.3g/20ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Normal immunoglobulin human 1.65g/10ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ferric derisomaltose 100mg/1ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ferric derisomaltose 500mg/5ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Ferric derisomaltose 1g/10ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Terlipressin 1mg/8.5ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Disodium folinate 200mg/4ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Disodium folinate 50mg/1ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Golimumab 50mg/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Golimumab 50mg/0.5ml solution for injection pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Insulin human 100units/ml solution for injection 3.15ml cartridges |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Mecobalamin 500micrograms/1ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Atracurium besilate 250mg/25ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Methotrexate 30mg/0.6ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adrenaline 150micrograms/0.15ml (1 in 1,000) solution for injection pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adalimumab 40mg/0.4ml solution for injection pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Adalimumab 40mg/0.4ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Potassium acetate 49% (potassium 50mmol/10ml) solution for injection 10ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Potassium acetate 19.6% (potassium 20mmol/10ml) solution for injection 10ml ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Potassium acetate 19.6% (potassium 20mmol/10ml) solution for injection 10ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Potassium acetate 19.6% (potassium 200mmol/100ml) solution for injection 100ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Glucose 2.5g/10ml / Phenol 250mg/10ml / Glycerol 2.5ml/10ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Moxifloxacin 0.5mg/0.5ml solution for injection pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Zinc sulfate 200micromol/10ml solution for injection vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Calcium gluconate 10% solution for injection 50ml vials |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gadodiamide 0.5mmol/ml solution for injection 10ml pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Atropine 40micrograms/2ml solution for injection ampoules |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Certolizumab pegol 200mg/1ml solution for injection pre-filled disposable devices |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|
Gadodiamide 0.5mmol/ml solution for injection 15ml pre-filled syringes |
Has manufactured dose form |
False |
Conventional release solution for injection |
Inferred relationship |
Existential restriction modifier |
|